Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BAMLANIVIMAB Cause Blood creatinine increased? 21 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 21 reports of Blood creatinine increased have been filed in association with BAMLANIVIMAB. This represents 0.4% of all adverse event reports for BAMLANIVIMAB.

21
Reports of Blood creatinine increased with BAMLANIVIMAB
0.4%
of all BAMLANIVIMAB reports
3
Deaths
15
Hospitalizations

How Dangerous Is Blood creatinine increased From BAMLANIVIMAB?

Of the 21 reports, 3 (14.3%) resulted in death, 15 (71.4%) required hospitalization, and 3 (14.3%) were considered life-threatening.

Is Blood creatinine increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for BAMLANIVIMAB. However, 21 reports have been filed with the FAERS database.

What Other Side Effects Does BAMLANIVIMAB Cause?

Dyspnoea (833) Infusion related reaction (663) Pyrexia (641) Chills (453) Oxygen saturation decreased (448) Nausea (422) Covid-19 (346) Cough (342) Covid-19 pneumonia (313) Hypoxia (310)

What Other Drugs Cause Blood creatinine increased?

EMTRICITABINE\TENOFOVIR DISOPROXIL (1,966) TENOFOVIR DISOPROXIL (1,460) TACROLIMUS (1,439) METHOTREXATE (1,401) SACUBITRIL\VALSARTAN (1,389) RITUXIMAB (1,265) EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL (1,112) METFORMIN (986) ECULIZUMAB (967) LENALIDOMIDE (959)

Which BAMLANIVIMAB Alternatives Have Lower Blood creatinine increased Risk?

BAMLANIVIMAB vs BAMLANIVIMAB\ETESEVIMAB BAMLANIVIMAB vs BARACLUDE BAMLANIVIMAB vs BARICITINIB BAMLANIVIMAB vs BARIUM BAMLANIVIMAB vs BARNIDIPINE

Related Pages

BAMLANIVIMAB Full Profile All Blood creatinine increased Reports All Drugs Causing Blood creatinine increased BAMLANIVIMAB Demographics